Warner Group’s Bristol-Myers Squibb BMY Stock Holding History

Warner Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452K	Buy	7,836 +3,918	+100%	+$225K	0.11%	86
2026 Q1	$238K	Buy	+3,918	New	+$228K	0.16%	72

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Warner Group's BMY Position: Q2 2026 in Review

Warner Group increased its Bristol-Myers Squibb (BMY) stake by 100% in Q2 2026, buying an estimated $225K and bringing the position to 7,836 shares worth $452K. The position accounts for 0.11% of the portfolio, ranked #86.

Warner Group first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Warner Group held 7,836 shares of Bristol-Myers Squibb worth $452K as of Q2 2026.
Warner Group bought 3,918 Bristol-Myers Squibb shares in Q2 2026, an estimated $225K.
Bristol-Myers Squibb made up 0.11% of Warner Group's portfolio in Q2 2026, its #86 holding.
Warner Group first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Warner Group's 13F filing for Q2 2026, filed 27 Jul 2026.